ArticleJournal of chemical theory and computation2026
Developing and Benchmarking Sage 2.3.0 with the AshGC Neural Network Charge Model.
Article in Journal of chemical theory and computation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reparameterization of the Amber RNA Force Field Non-Bonded Terms.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Partial atomic charges are a fundamental component underlying classical molecular simulations, but assigning charges remains a computational bottleneck; many common methods rely on quantum mechanical calculations that scale poorly with molecular size and are sensitive to the choice of conformer geometry. We introduce Open Force Field (OpenFF) AshGC, a new graph convolutional neural network charge model, as well as the Sage 2.3.0 small molecule force field for drug-like molecules parametrized to be consistent with AshGC. AshGC is designed to efficiently produce conformer-independent charges of semiempirical quality at linear cost for molecules of all sizes, from small molecules to macromolecules. AshGC largely generates charges within the range of other accepted AM1-BCC backends such as OpenEye's oequacpac and AmberTools' sqm, deviating most in smaller molecules between 4 and 9 heavy atoms, in negatively charged molecules, and areas of chemistry underrepresented in the training set, such as particular sulfur- and phosphorus-containing functional groups. We further present the development and performance of Sage 2.3.0, which has both Lennard-Jones and valence parameters that are retrained to be consistent with neural network charges for the first time. Benchmarks spanning gas-phase geometry optimization through protein-ligand binding free energies show Sage 2.3.0 performs comparably to earlier Sage releases, with modest improvements in condensed-phase properties and a slight decrease in nonaqueous solvation free energy accuracy. As with other OpenFF force fields, Sage 2.3.0 was validated in protein-ligand benchmarks to be compatible with Amber protein force fields. All data are publicly available, along with scripts and environments for reproducing the training and benchmarking of AshGC and Sage 2.3.0 at https://github.com/openforcefield/ashgc-v1.0-fit and https://github.com/openforcefield/ash-sage-rc2 respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.